Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Tools & Techniques Infectious diseases, Drug discovery, Informatics

A Universal Shot

I’ve recently been involved in a project to design a potential universal flu vaccine using bioinformatics (1). There will be a lot of people who after reading our paper will say (and indeed have said): been there, done that, didn’t work – give up! But we can’t really afford that attitude when it comes to influenza. Currently, our situation regarding the flu is like living in a region prone to storms; we have a fairly reliable drill for dealing with storms, but very occasionally there will be a hurricane – and the standard storm drill will be fairly useless when that happens. Standard vaccination regimes are unlikely to cut it during a pandemic. We can simply wait for the big one, shrug our shoulders and see what fate brings, thinking about ways to deal with it in the meantime – or we could try to prevent it. In other words, we shouldn’t give up on the development of a universal flu vaccine just because it’s a tough challenge to solve.

Read the full article now

Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Derek Gatherer

Derek Gatherer is a lecturer at Lancaster University

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register